BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25661002)

  • 21. CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis.
    Ha J; Choi HS; Lee Y; Kwon HJ; Song YW; Kim HH
    J Immunol; 2010 May; 184(9):4717-24. PubMed ID: 20357249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption.
    Guo H; Zhang J; Hao S; Jin Q
    Int J Mol Med; 2013 Aug; 32(2):296-306. PubMed ID: 23760678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
    Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
    Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
    Kondo H; Takeuchi S; Togari A
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.
    Carmody EE; Schwarz EM; Puzas JE; Rosier RN; O'Keefe RJ
    Arthritis Rheum; 2002 May; 46(5):1298-308. PubMed ID: 12115237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways.
    Ma X; Liu Y; Zhang Y; Yu X; Wang W; Zhao D
    Biochem Biophys Res Commun; 2014 Mar; 445(2):282-8. PubMed ID: 24491533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High extracellular Ca2+ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors.
    Shin MM; Kim YH; Kim SN; Kim GS; Baek JH
    Exp Mol Med; 2003 Jun; 35(3):167-74. PubMed ID: 12858015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A; Kudo O; Athanasou NA
    J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways.
    Choi HJ; Park YR; Nepal M; Choi BY; Cho NP; Choi SH; Heo SR; Kim HS; Yang MS; Soh Y
    Eur J Pharmacol; 2010 Jun; 636(1-3):28-35. PubMed ID: 20353769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice.
    Yoshimatsu M; Kitaura H; Fujimura Y; Kohara H; Morita Y; Yoshida N
    J Immunol Res; 2015; 2015():214878. PubMed ID: 26064997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.
    Yang S; Qi F; Tang C; Wang H; Qin H; Li X; Li J; Wang W; Zhao C; Gao H
    Oncol Lett; 2017 Feb; 13(2):898-904. PubMed ID: 28356976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
    Cai Z; Chen Q; Chen J; Lu Y; Xiao G; Wu Z; Zhou Q; Zhang J
    Neoplasia; 2009 Mar; 11(3):228-36. PubMed ID: 19242604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta.
    Weitzmann MN; Cenci S; Haug J; Brown C; DiPersio J; Pacifici R
    J Cell Biochem; 2000 May; 78(2):318-24. PubMed ID: 10842325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Competitive ELISA for quantifying serum CD147: reduction of soluble CD147 levels in cancer patient sera.
    Moonsom S; Tayapiwatana C; Wongkham S; Kongtawelert P; Kasinrerk W
    Hybridoma (Larchmt); 2010 Feb; 29(1):45-52. PubMed ID: 20199151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines.
    Shang YK; Li C; Liu ZK; Kong LM; Wei D; Xu J; Wang ZL; Bian H; Chen ZN
    Oncotarget; 2018 Feb; 9(16):12918-12931. PubMed ID: 29560120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination Therapy With CD147-Targeted Nanoparticles Carrying Phenformin Decreases Lung Cancer Growth.
    Pereira-Nunes A; Ferreira H; Abreu S; Guedes M; Neves NM; Baltazar F; Granja S
    Adv Biol (Weinh); 2023 Jul; 7(7):e2300080. PubMed ID: 37303292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of CD147 Attenuates Stroke-Associated Pneumonia Through Modulating Lung Immune Response in Mice.
    Jin R; Liu S; Wang M; Zhong W; Li G
    Front Neurol; 2019; 10():853. PubMed ID: 31447768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.